Utama › Kegagalan Jantung › Florida › Miami
Kajian klinikal Kegagalan Jantung di Miami, FL
14 kajian untuk Kegagalan Jantung sedang mencari peserta di lokasi dalam dan sekitar Miami (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
Mengambil pesertaFasa 3
- Research Site, Miami
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
Mengambil pesertaFasa 3
- University of Miami - Miller School of Medicine, Miami
- Infinite Clinical Research Inc, Miami
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
Mengambil pesertaFasa 3
- University of Miami, Miami
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
Mengambil pesertaFasa 3
- Research Site, Miami
- Research Site, Miami
- Research Site, Miami
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
Mengambil pesertaFasa 3
- Research Site, Miami
- Research Site, Miami
- Research Site, Miami
A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)
Mengambil pesertaFasa 3
- CON-10105, Miami, FL, Miami
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
Mengambil pesertaFasa 3
- Miami, FL Investigative Site 10105, Miami
- Miami, FL Investigative Site 10040, Miami
Feasibility and Efficacy Study of the CardioPulmonary Management (CPM) System in Patients With Chronic Heart Failure
Mengambil peserta
- Baptist Health South Florida, Miami
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Mengambil pesertaFasa 3
- Total Research Group LLC, Miami
- Infinite Clinical Research, Miami
- Future Life Clinical Trials, Miami
Assessment of CCM in HF With Higher Ejection Fraction
Mengambil peserta
- Baptist Health South Florida, Miami
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists
Mengambil pesertaFasa 3
- FIN-10105, Miami, FL, Miami
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
Mengambil peserta
- Baptist Health South Florida, Miami
A Study to Learn About the Study Medicine Called PF-07328948 in Adults With Heart Failure (BRANCH-HF)
Mengambil pesertaFasa 2
- Infinite Clinical Research, Miami
- Flourish Research Acquisition, LLC dba Flourish Research - North Miami, Miami
AN INTERNATIONAL, OBSERVATIONAL, BLINDED STUDY TO ASSESS THE PERFORMANCE OF THE CORDIO HEARO SYSTEM
Mengambil pesertaKajian pemerhatian
- Amavita Clinical Research, Miami
- Advance Medical Research Services Corp (AMRS), Miami
- Baptist Health (Miami Cardiac & Vascular Institute), Miami
Kajian Kegagalan Jantung di bandar lain
- New York City, NY51 kajian
- Boston, MA44 kajian
- Dallas, TX42 kajian
- Houston, TX36 kajian
- Cleveland, OH33 kajian
- Chicago, IL31 kajian
- Philadelphia, PA31 kajian
- San Francisco, CA29 kajian
- St. Louis, MO26 kajian
- Durham, NC26 kajian
- Atlanta, GA25 kajian
- Kansas City, MO25 kajian
Kajian lain di Miami
- Kanser Payudara42 kajian
- Kanser (semua jenis)36 kajian
- Kanser Paru-paru Bukan Sel Kecil31 kajian
- Kanser Prostat27 kajian
- Obesiti27 kajian
- Leukemia Mieloid Akut24 kajian
- Kanser Metastatik24 kajian
- Kanser Ovari23 kajian
- Berat Badan Berlebihan23 kajian
- Mieloma Pelbagai21 kajian
- Kolitis Ulseratif21 kajian
- Penyakit Alzheimer20 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 4 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.